Cargando…

Phenotypical changes and clinical significance of CD4(+)/CD8(+) T cells in SLE

OBJECTIVE: T cells display significant phenotypical changes and play multiple roles in promoting the immune response in SLE. The frequencies of T cell subpopulations in SLE are still not well understood. To better understanding the phenotypic abnormalities of T cells in SLE will help us to clarify d...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Shiwen, Zeng, Yanting, Li, Jiawei, Wang, Cuicui, Li, Weinian, He, Zhixiang, Ye, Jinghua, Li, Fangfei, Chen, Yi, Lin, Xiaojun, Yu, Na, Cai, Xiaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226979/
https://www.ncbi.nlm.nih.gov/pubmed/35732344
http://dx.doi.org/10.1136/lupus-2022-000660
_version_ 1784734047648350208
author Yuan, Shiwen
Zeng, Yanting
Li, Jiawei
Wang, Cuicui
Li, Weinian
He, Zhixiang
Ye, Jinghua
Li, Fangfei
Chen, Yi
Lin, Xiaojun
Yu, Na
Cai, Xiaoyan
author_facet Yuan, Shiwen
Zeng, Yanting
Li, Jiawei
Wang, Cuicui
Li, Weinian
He, Zhixiang
Ye, Jinghua
Li, Fangfei
Chen, Yi
Lin, Xiaojun
Yu, Na
Cai, Xiaoyan
author_sort Yuan, Shiwen
collection PubMed
description OBJECTIVE: T cells display significant phenotypical changes and play multiple roles in promoting the immune response in SLE. The frequencies of T cell subpopulations in SLE are still not well understood. To better understanding the phenotypic abnormalities of T cells in SLE will help us to clarify disease immunopathology and to find promising biomarkers for disease monitoring and control. METHODS: Peripheral blood CD4(+) and CD8(+) T cells and their subsets were determined by flow cytometry. Forty-one active SLE patients were selected, including 28 new-onset patients and 13 relapsing patients. One hundred healthy controls (HCs) were enrolled as the control group. The percentages of these cell subsets between patients with SLE and HCs and their relationships with disease activity and autoantibody titers were analysed. Thirteen of 28 new-onset SLE patients were assessed before and after treatment. The changes in the frequencies of these cell subsets and their relationships with renal response were analysed. RESULTS: There was a broad range of anomalies in the proportion of T cell subsets in patients with SLE compared with that of the HCs. Compared with the HCs, a higher frequency of memory T cells and a lower frequency of naïve T cells were noted in patients with SLE. In addition, an imbalance of CD28(+) and CD28(−) cells in CD4(+) T cells was observed in patients with SLE. We found that the expanded CD4(+)CD28(−) T cells did not decrease after treatment in patients who had impaired renal responses. It was very interesting to exhibit a negative correlation in the frequency between the CD4(+)CD28(−) T cells and T regulatory (Treg) cells and a positive correlation between the frequency of CD4(+)CD28(+) T cells and Treg cells in this study. Increased CD8(+)HLADR(+) T cell and CD8(+)CD38(+)HLADR(+) T cell counts were observed in patients with SLE, suggesting an impaired cytotoxic capacity of CD8(+) T cells in SLE. Additionally, we found that CD8(+)CD38(+)HLADR(+) T cells were closely associated with disease activity, autoantibody titres and renal prognosis. CD4(+) CXCR5(−)PD1(+) T cells were expanded in patients with SLE in this study and were associated with disease activity in SLE. Th1 (T helper type 1) cells and Treg cells were decreased, but frequencies of T follicular helper (Tfh) cells, Th2 cells, Th17 cells and Tfh17 cells were increased. A strong correlation between Th17 cells and Tregs with renal involvement was observed in this study. CONCLUSION: The proportions of CD4(+)CD28(−) T cells, CD4(+)CXCR5(−)PD1(+) T cells, CD8(+)HLADR(+) T cells and CD8(+)CD38(+)HLADR(+) T cells increased in patients with SLE and could be associated with disease activity and renal prognosis.
format Online
Article
Text
id pubmed-9226979
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-92269792022-07-08 Phenotypical changes and clinical significance of CD4(+)/CD8(+) T cells in SLE Yuan, Shiwen Zeng, Yanting Li, Jiawei Wang, Cuicui Li, Weinian He, Zhixiang Ye, Jinghua Li, Fangfei Chen, Yi Lin, Xiaojun Yu, Na Cai, Xiaoyan Lupus Sci Med Biomarker Studies OBJECTIVE: T cells display significant phenotypical changes and play multiple roles in promoting the immune response in SLE. The frequencies of T cell subpopulations in SLE are still not well understood. To better understanding the phenotypic abnormalities of T cells in SLE will help us to clarify disease immunopathology and to find promising biomarkers for disease monitoring and control. METHODS: Peripheral blood CD4(+) and CD8(+) T cells and their subsets were determined by flow cytometry. Forty-one active SLE patients were selected, including 28 new-onset patients and 13 relapsing patients. One hundred healthy controls (HCs) were enrolled as the control group. The percentages of these cell subsets between patients with SLE and HCs and their relationships with disease activity and autoantibody titers were analysed. Thirteen of 28 new-onset SLE patients were assessed before and after treatment. The changes in the frequencies of these cell subsets and their relationships with renal response were analysed. RESULTS: There was a broad range of anomalies in the proportion of T cell subsets in patients with SLE compared with that of the HCs. Compared with the HCs, a higher frequency of memory T cells and a lower frequency of naïve T cells were noted in patients with SLE. In addition, an imbalance of CD28(+) and CD28(−) cells in CD4(+) T cells was observed in patients with SLE. We found that the expanded CD4(+)CD28(−) T cells did not decrease after treatment in patients who had impaired renal responses. It was very interesting to exhibit a negative correlation in the frequency between the CD4(+)CD28(−) T cells and T regulatory (Treg) cells and a positive correlation between the frequency of CD4(+)CD28(+) T cells and Treg cells in this study. Increased CD8(+)HLADR(+) T cell and CD8(+)CD38(+)HLADR(+) T cell counts were observed in patients with SLE, suggesting an impaired cytotoxic capacity of CD8(+) T cells in SLE. Additionally, we found that CD8(+)CD38(+)HLADR(+) T cells were closely associated with disease activity, autoantibody titres and renal prognosis. CD4(+) CXCR5(−)PD1(+) T cells were expanded in patients with SLE in this study and were associated with disease activity in SLE. Th1 (T helper type 1) cells and Treg cells were decreased, but frequencies of T follicular helper (Tfh) cells, Th2 cells, Th17 cells and Tfh17 cells were increased. A strong correlation between Th17 cells and Tregs with renal involvement was observed in this study. CONCLUSION: The proportions of CD4(+)CD28(−) T cells, CD4(+)CXCR5(−)PD1(+) T cells, CD8(+)HLADR(+) T cells and CD8(+)CD38(+)HLADR(+) T cells increased in patients with SLE and could be associated with disease activity and renal prognosis. BMJ Publishing Group 2022-06-22 /pmc/articles/PMC9226979/ /pubmed/35732344 http://dx.doi.org/10.1136/lupus-2022-000660 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Biomarker Studies
Yuan, Shiwen
Zeng, Yanting
Li, Jiawei
Wang, Cuicui
Li, Weinian
He, Zhixiang
Ye, Jinghua
Li, Fangfei
Chen, Yi
Lin, Xiaojun
Yu, Na
Cai, Xiaoyan
Phenotypical changes and clinical significance of CD4(+)/CD8(+) T cells in SLE
title Phenotypical changes and clinical significance of CD4(+)/CD8(+) T cells in SLE
title_full Phenotypical changes and clinical significance of CD4(+)/CD8(+) T cells in SLE
title_fullStr Phenotypical changes and clinical significance of CD4(+)/CD8(+) T cells in SLE
title_full_unstemmed Phenotypical changes and clinical significance of CD4(+)/CD8(+) T cells in SLE
title_short Phenotypical changes and clinical significance of CD4(+)/CD8(+) T cells in SLE
title_sort phenotypical changes and clinical significance of cd4(+)/cd8(+) t cells in sle
topic Biomarker Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226979/
https://www.ncbi.nlm.nih.gov/pubmed/35732344
http://dx.doi.org/10.1136/lupus-2022-000660
work_keys_str_mv AT yuanshiwen phenotypicalchangesandclinicalsignificanceofcd4cd8tcellsinsle
AT zengyanting phenotypicalchangesandclinicalsignificanceofcd4cd8tcellsinsle
AT lijiawei phenotypicalchangesandclinicalsignificanceofcd4cd8tcellsinsle
AT wangcuicui phenotypicalchangesandclinicalsignificanceofcd4cd8tcellsinsle
AT liweinian phenotypicalchangesandclinicalsignificanceofcd4cd8tcellsinsle
AT hezhixiang phenotypicalchangesandclinicalsignificanceofcd4cd8tcellsinsle
AT yejinghua phenotypicalchangesandclinicalsignificanceofcd4cd8tcellsinsle
AT lifangfei phenotypicalchangesandclinicalsignificanceofcd4cd8tcellsinsle
AT chenyi phenotypicalchangesandclinicalsignificanceofcd4cd8tcellsinsle
AT linxiaojun phenotypicalchangesandclinicalsignificanceofcd4cd8tcellsinsle
AT yuna phenotypicalchangesandclinicalsignificanceofcd4cd8tcellsinsle
AT caixiaoyan phenotypicalchangesandclinicalsignificanceofcd4cd8tcellsinsle